Algernon Pharmaceuticals Reveals $500,000 Private Placement Deal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 06 2025
0mins
Private Placement Announcement: Algernon Health has announced a non-brokered private placement aiming to raise $500,000 by issuing units at $0.07 each.
Unit Composition: Each unit will consist of one Class A common share and one-half common share purchase warrant, with specific exercise prices and timelines for the warrants.
Warrant Exercise Price Structure: The exercise price for the common warrants will increase over time, starting at $0.15 and potentially reaching $0.50 by the second anniversary of issuance.
Closing Timeline: The offering is expected to close in tranches on or before November 30, 2025.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
